Literature DB >> 21197386

METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Alexandra C McPherron1.   

Abstract

Myostatin is a member of the transforming growth factor β superfamily of secreted growth factors that negatively regulates skeletal muscle size. Mice null for the myostatin gene have a dramatically increased mass of individual muscles, reduced adiposity, increased insulin sensitivity, and resistance to obesity. Myostatin inhibition in adult mice also increases muscle mass which raises the possibility that anti-myostatin therapy could be a useful approach for treating diseases such as obesity or diabetes in addition to muscle wasting diseases. In this review I will describe the present state of our understanding of the role of myostatin and the closely related growth factor growth/differentiation factor 11 on metabolism.

Entities:  

Year:  2010        PMID: 21197386      PMCID: PMC3011861          DOI: 10.2174/187152210793663810

Source DB:  PubMed          Journal:  Immunol Endocr Metab Agents Med Chem        ISSN: 1871-5222


  129 in total

Review 1.  The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.

Authors:  A Matsakas; P Diel
Journal:  Int J Sports Med       Date:  2005-03       Impact factor: 3.118

Review 2.  The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.

Authors:  Ketan Patel; Helge Amthor
Journal:  Neuromuscul Disord       Date:  2005-01-11       Impact factor: 4.296

3.  Inverse associations between muscle mass, strength, and the metabolic syndrome.

Authors:  Evan Atlantis; Sean A Martin; Matthew T Haren; Anne W Taylor; Gary A Wittert
Journal:  Metabolism       Date:  2009-07       Impact factor: 8.694

4.  Insulin resistance. Prosperity's plague.

Authors:  Gary Taubes
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

5.  Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning.

Authors:  S Paul Oh; Chang-Yeol Yeo; Youngjae Lee; Heindrich Schrewe; Malcolm Whitman; En Li
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

6.  Expression of myostatin pro domain results in muscular transgenic mice.

Authors:  J Yang; T Ratovitski; J P Brady; M B Solomon; K D Wells; R J Wall
Journal:  Mol Reprod Dev       Date:  2001-11       Impact factor: 2.609

Review 7.  Myostatin and its implications on animal breeding: a review.

Authors:  R H S Bellinge; D A Liberles; S P A Iaschi; P A O'brien; G K Tay
Journal:  Anim Genet       Date:  2005-02       Impact factor: 3.169

8.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.

Authors:  Neil M Wolfman; Alexandra C McPherron; William N Pappano; Monique V Davies; Kening Song; Kathleen N Tomkinson; Jill F Wright; Liz Zhao; Suzanne M Sebald; Daniel S Greenspan; Se-Jin Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

9.  Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle.

Authors:  Keith Foster; Ian R Graham; Anthony Otto; Helen Foster; Capucine Trollet; Paul J Yaworsky; Frank S Walsh; Dale Bickham; Nancy A Curtin; Susannah L Kawar; Ketan Patel; George Dickson
Journal:  Rejuvenation Res       Date:  2009-04       Impact factor: 4.663

10.  Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.

Authors:  Michael R Morissette; Stuart A Cook; Cattleya Buranasombati; Michael A Rosenberg; Anthony Rosenzweig
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-16       Impact factor: 4.249

View more
  52 in total

1.  Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.

Authors:  Tommaso Poggioli; Ana Vujic; Peiguo Yang; Claudio Macias-Trevino; Aysu Uygur; Francesco S Loffredo; James R Pancoast; Miook Cho; Jill Goldstein; Rachel M Tandias; Emilia Gonzalez; Ryan G Walker; Thomas B Thompson; Amy J Wagers; Yick W Fong; Richard T Lee
Journal:  Circ Res       Date:  2015-10-21       Impact factor: 17.367

Review 2.  The influence of skeletal muscle on systemic aging and lifespan.

Authors:  Fabio Demontis; Rosanna Piccirillo; Alfred L Goldberg; Norbert Perrimon
Journal:  Aging Cell       Date:  2013-07-17       Impact factor: 9.304

Review 3.  Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.

Authors:  Stefano Rivella
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

4.  Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging.

Authors:  Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Mohammed Khadeer; Norman Salem; Luigi Ferrucci; Richard D Semba
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

5.  A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.

Authors:  Richard D Semba; Pingbo Zhang; Min Zhu; Elisa Fabbri; Marta Gonzalez-Freire; Ruin Moaddel; Minghui Geng-Spyropoulos; Luigi Ferrucci
Journal:  Proteomics       Date:  2017-08       Impact factor: 3.984

Review 6.  Interorgan Communication Pathways in Physiology: Focus on Drosophila.

Authors:  Ilia A Droujinine; Norbert Perrimon
Journal:  Annu Rev Genet       Date:  2016-10-10       Impact factor: 16.830

7.  Expression of myostatin in neural cells of the olfactory system.

Authors:  Shunsuke Iwasaki; Masato Miyake; Hitoshi Watanabe; Eri Kitagawa; Kouichi Watanabe; Shyuichi Ohwada; Haruki Kitazawa; Michael T Rose; Hisashi Aso
Journal:  Mol Neurobiol       Date:  2012-09-02       Impact factor: 5.590

8.  Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation.

Authors:  Qian Wang; Alexandra C McPherron
Journal:  J Physiol       Date:  2012-03-05       Impact factor: 5.182

9.  Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.

Authors:  Maria T Vamvini; Konstantinos N Aronis; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

10.  Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.

Authors:  Marissa J Schafer; Elizabeth J Atkinson; Patrick M Vanderboom; Brian Kotajarvi; Thomas A White; Matthew M Moore; Charles J Bruce; Kevin L Greason; Rakesh M Suri; Sundeep Khosla; Jordan D Miller; H Robert Bergen; Nathan K LeBrasseur
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.